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Assessment of reward responsiveness in the response bias
probabilistic reward task in rats: implications for cross-species
translational research
A Der-Avakian1,3, MS D’Souza1,3, DA Pizzagalli2,4 and A Markou1,4
Mood disorders, such as major depressive disorder, are characterized by abnormal reward responsiveness. The Response Bias
Probabilistic Reward Task (hereafter referred to as probabilistic reward task (PRT)) quantiﬁes reward responsiveness in human
subjects, and an equivalent animal assessment is needed to facilitate preclinical translational research. Thus, the goals of the
present studies were to develop, validate and characterize a rat analog of the PRT. Adult male Wistar and Long–Evans rats were
trained in operant testing chambers to discriminate between two tone stimuli that varied in duration (0.5 and 2 s). During a
subsequent test session consisting of 100 trials, the two tones were made ambiguous (0.9 and 1.6 s) and correct identiﬁcation of
one tone was reinforced with a food pellet three times more frequently than the other tone. In subsequent experiments, Wistar rats
were administered either a low dose of the dopamine D2/D3 receptor agonist pramipexole (0.1mg kg
 1, subcutaneous) or the
psychostimulant amphetamine (0.5mg kg 1, intraperitoneal) before the test session. Similar to human subjects, both rat strains
developed a response bias toward the more frequently reinforced stimulus, reﬂecting robust reward responsiveness. Mirroring prior
ﬁndings in humans, a low dose of pramipexole blunted response bias. Moreover, in rats, amphetamine potentiated response bias.
These results indicate that in rats, reward responsiveness can be quantiﬁed and bidirectionally modulated by pharmacological
manipulations that alter striatal dopamine transmission. Thus, this new procedure in rats, which is conceptually and procedurally
analogous to the one used in humans, provides a reverse translational platform to investigate abnormal reward responsiveness
across species.
Translational Psychiatry (2013) 3, e297; doi:10.1038/tp.2013.74; published online 27 August 2013
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INTRODUCTION
Deﬁcits in reward processing characterize a broad array of
neuropsychiatric disorders, including major depressive disorder
(MDD), substance abuse and schizophrenia.1 Such impairments
may include deﬁcits in hedonic capacity or pleasure (that is,
anhedonia), lack of motivation to pursue rewards, lack of effective
integration of reward value with planning of actions or deﬁcits in
reinforcement learning.2–4 Unfortunately, most clinical subjective
assessments of anhedonia fail to capture various aspects of reward
deﬁcits. Furthermore, the use of subjective assessments that rely
on an individual’s ability to recall past or imagine hypothetical
pleasurable experiences is impossible to model in laboratory
animals, limiting the potential impact of animal research on the
discovery of new treatments for reward-related deﬁcits in
neuropsychiatric disorders.
To address this issue, clinical researchers have begun to develop
objective, laboratory-based tasks to investigate discrete reward
processes. One such task is the Response Bias Probabilistic Reward
Task (hereafter referred to as probabilistic reward task (PRT)), a
laboratory-based task designed to objectively assess reward
responsiveness, that is, participants’ ability to modulate behavior
as a function of reward.5 In this task, a signal detection approach
is used, whereby subjects must discriminate between two
ambiguous stimuli (for example, mouths varying slightly in
length on a cartoon face) displayed rapidly on a computer
screen in order to receive a monetary reward. As such, this task is
different than classic probabilistic reward tasks where there is no
ambiguity about the identity of the stimuli. Unbeknownst to the
subjects, correct identiﬁcation of one stimulus is reinforced three
times more frequently than the other stimulus. Under these
experimental circumstances, healthy subjects reliably develop a
response bias (that is, preference) for the stimulus that is
reinforced more frequently, regardless of which stimulus was
actually presented. Thus, reward responsiveness assessed in this
task reﬂects the rapid shaping of future behavioral choices based
on prior reinforcement experiences.
Subjects with MDD,6–8 euthymic subjects with bipolar disorder9
and healthy subjects with elevated depressive symptoms5 fail to
develop this biased response for the more frequently reinforced
stimulus. Accordingly, in spite of being exposed to the same
differential reinforcement schedule, these subjects respond
similarly to both stimuli, reﬂecting decreased responsiveness to
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rewards. Moreover, response bias was found to predict current
and future anhedonic symptoms in both nonclinical and clinical
samples5,9,10 and predict the persistence of MDD diagnosis in
MDD inpatients.8 Importantly, the objective nature of this task
makes it ideal to develop and use as a translational tool to
measure reward responsiveness across species.
Various key aspects of reward processing, particularly with
regard to reinforcement learning and motivation, have been
hypothesized to involve mesolimbic dopamine neurotransmission
(for review, see refs 11–14). Using the PRT, Pizzagalli et al.15
demonstrated that a single low dose of the dopamine D2/D3
receptor agonist pramipexole—which at low doses is hypothe-
sized to decrease extracellular dopamine levels via autoreceptor
stimulation—impaired the development of response bias in
psychiatrically healthy individuals. Deﬁcits in striatal dopamine
function in MDD have been described,16–19 suggesting that
decreased striatal dopamine function in humans with MDD may
contribute to blunted reward responsiveness.
The goals of the present study were twofold. First, we aimed to
develop a new behavioral task in rats that was conceptually and
procedurally identical to the human version of the PRT. Once the
task was developed and the rats’ behavior was characterized, the
second goal was to determine whether dopaminergic manipula-
tions would bidirectionally alter reward responsiveness. In light
of prior ﬁndings in humans, we hypothesized that: (1) healthy
rats would develop a response bias for a more frequently
reinforced stimulus, similar to healthy human subjects;5,6 and (2)
pharmacological manipulations that block (that is, low doses of
pramipexole) or enhance (that is, amphetamine) striatal dopamine




A total of 12 male Wistar and 12 male Long–Evans rats (Charles River
Laboratories, Raleigh, NC, USA) were used in experiment 1. A separate
group of 24 male Wistar rats was used in experiments 2 and 3 (that is, the
same rats were used for both experiments; for details, see Supplementary
Methods). All procedures were conducted in accordance with the
guidelines from the National Institutes of Health and the Association for
the Assessment and Accreditation of Laboratory Animal Care and were
approved by the Institutional Animal Care and Use Committee.
Apparatus
Behavioral training and testing were conducted in operant testing
chambers that consisted of two metal retractable levers, a food receptacle
located between the levers and a single speaker positioned above the food
receptacle (Med Associates, St Albans, VT, USA). Tones were generated
using a multipurpose sound generator, and all programs and data
collection were controlled by a computer that ran MED-PC IV software
(Med Associates; see Supplementary Methods).
Procedure
Tone discrimination training. The training procedure was developed to
mirror the PRT instructions presented to humans5 (see Supplementary
Methods). Brieﬂy, rats were food restricted and trained to discriminate
between two tone stimuli that varied in duration (5 kHz, 60 dB, 0.5 or 2 s)
by pressing one of the two levers associated with each tone. Tone
durations and lever sides were counterbalanced across subjects, and tones
were presented in a random order over 100 trials. Each trial was initiated
with presentation of a tone, after which the levers were extended, and rats
had a 5-s limited hold period to respond. In each trial, correct identiﬁcation
of the tone stimuli resulted in a single 45mg food pellet (Test Diet 5TUM,
Richmond, IN, USA). Both levers retracted after a correct, incorrect or
omitted response, followed by a variable intertrial interval between 5 and
8 s. Rats were trained daily until they achieved at least 70% accuracy for 5
consecutive days.
Experiment 1: performance of different rat strains in the response bias
PRT. Optimal tone durations and reinforcement schedules were deter-
mined for testing (see Supplementary Results). During the test session,
tone durations that were more ambiguous than the training tones (that is,
0.9 and 1.6 s) were reinforced for 60% and 20% of correct responses
(counterbalanced across subjects) over 100 trials, which is identical to the
3:1 reinforcement ratio used in the human PRT.5 The stimulus paired with
three times more frequent reward was referred to as the ‘rich stimulus’,
whereas the other stimulus was referred to as the ‘lean stimulus’.
Experiment 2: effects of pramipexole on performance in the response bias
PRT. Rats underwent tone discrimination training as described above and
were habituated to the pramipexole administration procedure (see
Supplementary Methods). On the testing day, half of the rats were
injected with 0.1mg kg 1 pramipexole and half with saline (1ml kg 1,
subcutaneous) 60min before the test session. The test parameters were
exactly the same as in experiment 1. After the test, training resumed for 5
days (that is, 0.5 and 2 s tone durations; 60% equal reinforcement),
followed by a second test. Rats that received pramipexole during the ﬁrst
test were administered saline during the second test and vice versa.
Experiment 3: effects of amphetamine on performance in the response
bias PRT. After the pramipexole experiment, training resumed for
9 days, followed by habituation to the amphetamine administration
procedure (see Supplementary Methods). On the day of testing, half
of the rats were injected with 0.5mg kg 1 amphetamine and half with
saline (1ml kg 1, intraperitoneal) 15min before the test. The test
parameters were exactly the same as in experiment 1. After the test,
training resumed for 9 days, followed by another test. Rats that received
amphetamine during the ﬁrst test were administered saline during the
second test and vice versa.
Drugs
Rats were administered pramipexole dihydrochloride (Tocris Bioscience,
Ellisville, MO, USA), D-amphetamine sulfate (Sigma, St Louis, MO, USA) or
sterile 0.9% saline. The pramipexole dose used in the present study has
been shown to suppress ﬁring of ventral tegmental area dopaminergic
neurons20,21 and striatal dopamine levels.22,23 This inhibitory effect on
dopamine transmission parallels the decrease in ventral striatal activity in
humans after administration of a low dose of pramipexole (that is,
0.5mg),24 which was also used in the human PRT.15 The amphetamine
dose used in the present study has been shown to enhance brain reward
function25,26 and elevate striatal dopamine levels without inducing
stereotypy.27 All solutions were prepared fresh daily and administered in
a volume of 1ml kg 1.
Data and statistical analyses
Data collected by the MED-PC IV software included correct, incorrect and
omitted responses and reaction times for the rich and lean stimuli for each
individual trial and cumulated across blocks 1 (trials 1–33), 2 (trials 34–67)
and 3 (trials 68–100). For each block, response bias, the primary dependent
variable, was calculated as:
log b ¼ 0:5log ð RichCorrectþ 0:5½ ½LeanIncorrect þ 0:5Þ=ð½RichIncorrect þ 0:5½LeanCorrect þ 0:5Þ½ 
exactly as in the human task. A value of 0.5 was added to each cell to allow
for calculations in cases of cells with a value of 0. A response bias arises
when subjects tend to correctly classify the rich stimulus (that is, the
stimulus associated with three times more frequent reward) and mis-
classify the lean stimulus (that is, pressing the lever associated with the rich
stimulus when the stimulus presented was lean). As in humans, discrimi-
nability was calculated for each block as:
log d ¼ 0:5log ð RichCorrect þ 0:5½ ½LeanCorrect þ 0:5Þ=ð½RichIncorrect þ 0:5½LeanIncorrect þ 0:5Þ½ 
Discriminability captures the ability to differentiate between the stimuli,
and can thus be taken as a proxy of task difﬁculty. In addition, accuracy
(that is, number of correct responses/(numbers of correctþ incorrect
responses)) and reaction time were averaged within each block for each
treatment group and stimulus type (that is, rich/lean), exactly as in the
human task. Rats that could not successfully discriminate the two training
tones (o70% accuracy in the training phase) were excluded from analyses
and further testing (see Results). Moreover, because development of
response bias is dependent on the ratio of rich vs lean reinforcements (that
is, 3:1) and because rats were reinforced as a percentage of correct
responses, rats were excluded if accuracy for either stimulus was o30%
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during either drug or vehicle test sessions, which resulted in insufﬁcient
reinforcements for that stimulus.
Response bias and discriminability scores were analyzed using a two-
way analysis of covariance (ANCOVA; see below for covariate description),
with Block as a within-subject factor and Rat Strain (experiment 1) as a
between-subject factor or Drug Treatment (experiments 2 and 3) as a
within-subject factor. To determine whether order of drug/vehicle
administration affected response bias in experiments 2 and 3, Order was
analyzed as a within-subject factor in a separate ANCOVA. Accuracy and
reaction time were analyzed using similar ANCOVAs, in which Stimulus
Type (rich vs lean) was an additional within-subject factor. Some rats
responded asymmetrically for one or the other stimulus when equally
reinforced during training sessions, suggesting that some degree of
inherent bias was present during test sessions for these subjects,
regardless of the differential reinforcement. Thus, variability of inherent
response patterns was controlled for using a covariate, deﬁned as the
change in response bias between the ﬁrst and third blocks during the
training sessions, when both stimuli were equally reinforced, before each
test day. For experiments 2 and 3, which involved within-subject testing,
the change in response bias from both pretest training sessions was
averaged.
Across ANCOVAs, signiﬁcant effects were followed by post hoc t-tests.
The level of signiﬁcance was set at 0.05. A Greenhouse–Geisser correction
was used when appropriate.
RESULTS
Experiment 1: performance of different rat strains in the response
bias PRT
One Long–Evans rat was excluded because of insufﬁcient accuracy
during training (o70%), leaving 11 Long–Evans and 12 Wistar rats
for analyses. The mean (±s.e.m.) days to train Wistar and Long–
Evans rats were 39.42 (±1.72) and 44.82 (±2.00) days,
respectively.
Response bias. The Block Rat Strain ANCOVA (covariate: inher-
ent bias during training) revealed only a main effect of Block
(F2, 40¼ 7.19, Po0.01; all other P40.49), suggesting that both
strains displayed a similar increase in response bias over time
(Figure 1a). Relative to block 1, response bias in blocks 2 and 3 was
signiﬁcantly higher (all t2243.06, Po0.01), indicating that the
differential reinforcement schedule had the intended effects.
Discriminability. No signiﬁcant effects emerged (all Fo2.22,
P40.15), indicating that task difﬁculty remained consistent
throughout blocks for both strains (Figure 1b).
Accuracy. The Block Rat Strain Stimulus ANCOVA revealed a
main effect of Stimulus (F1,20¼ 29.51, Po0.001) and a Block
Stimulus interaction (F2, 40¼ 5.78, Po0.01). Consistent with the
differential reinforcement schedule, accuracy of both rat strains
combined was signiﬁcantly higher for the rich vs lean stimulus in
each block (all t2242.26, Po0.034). Moreover, accuracy for the
rich and lean stimuli increased and decreased, respectively, from
early to later blocks (Figures 1c and d).
Reaction time. The three-way ANCOVA revealed signiﬁcant main
effects of Block (F2, 40¼ 8.09, Po0.001), Stimulus (F1, 20¼ 4.75,
Po0.05) and Rat Strain (F1, 20¼ 15.94, Po0.001). Post hoc tests
indicated that reaction times were signiﬁcantly shorter in blocks 2
and 3 relative to block 1 when data from both strains were
combined (Po0.02). As expected, reaction times were shorter for
the rich vs lean stimulus when data were combined across rat
strains and blocks. Overall, Wistar rats had signiﬁcantly slower
reaction times relative to Long–Evans rats. The Block Stimulus
(F2, 40¼ 2.75, P¼ 0.076) and Rat Strain Stimulus (F1, 20¼ 3.16,
P¼ 0.091) interactions approached signiﬁcance. Unlike Wistar rats
(t11¼  2.78, Po0.05; Figure 1e), Long–Evans rats did not show
signiﬁcantly shorter reaction times for the rich vs lean stimulus
(t10¼  0.17, P¼ 0.87; Figure 1f). Based on the discriminability and
reaction time patterns, only Wistar rats were used in subsequent
experiments.
Experiment 2: effects of pramipexole on performance in the
response bias PRT
Two rats were excluded because of insufﬁcient accuracy during
training (o70%). Six rats were excluded because of insufﬁcient
accuracy for either tone stimulus during the pramipexole or saline
tests (that is, o30%). Thus, data from 16 rats were available. The
mean (±s.e.m.) days to train Wistar rats for experiments 2 and 3
were 35.06 (±1.67) days.
Response bias. Response bias was lower in pramipexole-treated
rats relative to saline-treated rats (Drug Treatment: F1, 14¼ 5.85,
Po0.05; Greenhouse–Geisser: 0.677; Figure 2a). No other effects,
including order effects, emerged.
Discriminability. Discriminability was lower in pramipexole-trea-
ted rats relative to saline-treated rats (Drug Treatment: F1, 14¼ 7.38,
Po0.05; Figure 2b). No other effects were observed.
Accuracy. The Drug Treatment Block Stimulus Type ANCOVA
revealed a Drug Treatment effect (F1, 14¼ 9.17, Po0.01), which was
attributable to signiﬁcantly lower overall accuracy in the
pramipexole relative to saline condition. Critically, this effect was
moderated by a Drug Treatment Stimulus Type interaction
(F1, 14¼ 4.86, Po0.05). Post hoc analyses revealed that saline-
treated rats were signiﬁcantly more accurate for the rich vs lean
stimulus (t15¼ 4.04, Po0.001; Figure 2c), whereas pramipexole-
treated rats had similar accuracy for rich and lean stimuli
(Figure 2d). In addition, relative to saline, pramipexole induced
lower rich stimulus accuracy (t15¼ 2.87, Po0.05).
Reaction time. The three-way ANCOVA revealed a main effect of
Drug Treatment (F1, 14¼ 33.24, Po0.001), because of overall
signiﬁcantly slower reaction times for the pramipexole condition
relative to the saline condition. A signiﬁcant Drug Treatment
Block Stimulus Type interaction was found (F2, 28¼ 3.64, Po0.05).
Follow-up analyses revealed, however, no further signiﬁcant
differences (data not shown).
Experiment 3: effects of amphetamine on performance in the
response bias PRT
Two rats were excluded because of insufﬁcient accuracy during
training (o70%), leaving 22 rats for statistical analyses.
Response bias. There was a signiﬁcant main effect of Drug
Treatment (F1, 20¼ 4.40, Po0.05), which was attributable to overall
higher response bias in amphetamine-treated rats relative to
saline-treated rats (Figure 3a), as well as a main effect of Block
(F2, 40¼ 8.25, Po0.001). Response bias systematically increased
from blocks 1 to 3 (all t2142.24, all Po0.036). No other effects,
including order effects, emerged.
Discriminability. There was only a main effect of Block (F2, 40¼
4.69, Po0.05; Figure 3b), which was because of signiﬁ-
cantly higher discriminability in blocks 2 and 3 relative to block 1
(all t2142.35, Po0.029).
Accuracy. There was a signiﬁcant main effect of Stimulus Type
(F1, 20¼ 31.87, Po0.001) and signiﬁcant Drug Treatment Stimulus
Type (F1, 20¼ 4.52, Po0.05) and Block Stimulus Type (F2, 40¼ 7.38,
Po0.01; Greenhouse–Geisser: 0.787) interactions. Post hoc
analyses revealed that although both treatment groups were
signiﬁcantly more accurate for the rich vs lean stimulus,
amphetamine-treated rats were signiﬁcantly more accurate for
the rich stimulus than saline-treated rats (all t2142.19, all
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Po0.040; Figures 3c and d). With regard to the Block Stimulus
Type interaction, post hoc tests indicated that accuracy for the rich
stimulus increased systematically from blocks 1 to 3 (all t2142.27,
Po0.034), whereas lean accuracy did not differ across blocks (all
P40.23). Moreover, for blocks 2 and 3, rich stimulus accuracy was
signiﬁcantly higher than lean stimulus accuracy (all t2145.77,
Po0.001).
Reaction time. There was only a signiﬁcant Drug Treatment
Block interaction (F2, 40¼ 7.29, Po0.01). Post hoc analyses revealed
that amphetamine-treated rats were signiﬁcantly slower to
respond than saline-treated rats during block 1, but not during
blocks 2 and 3 (t21¼  2.71, Po0.05). Moreover, for ampheta-
mine-treated rats, reaction times were signiﬁcantly faster for
blocks 2 and 3 relative to block 1 (all t2142.16, Po0.042; data not
shown).
DISCUSSION
Using procedures that are analogous to the human Response Bias
PRT,5 we developed a new behavioral task to assess reward
responsiveness in rats. Reward responsiveness reﬂects the
modulation of a behavioral choice as a function of prior reinforce-
ment history. Under baseline conditions, rats, like healthy human
subjects,5 developed a response bias for the more frequently
reinforced of two ambiguous stimuli, reﬂecting robust reward
responsiveness. Furthermore, similar to the effects of pramipexole
in humans tested with the PRT,15 administration of a low dose of
pramipexole in rats attenuated response bias, which demonstrates
important cross-species concordance. In addition, amphetamine
treatment potentiated response bias in rats. Taken together,
these data indicate that reward responsiveness can be quantiﬁed
in rats and bidirectionally modulated by pharmacological
manipulations that alter striatal dopamine neurotransmission,
and monoamine neurotransmission in general in the case of
amphetamine.
Consistent with data from healthy human subjects,5 both rat
strains (Wistar and Long–Evans) displayed a positive response bias
and comparable discriminability, reﬂecting a similar ability to
differentiate between the two stimuli. In addition, consistent with
the imposed differential reinforcement schedule, accuracy for
the rich stimulus improved and accuracy for the lean stimulus
Figure 1. Response bias, discriminability, accuracy and reaction time in Wistar and Long–Evans rats. (a) Response bias gradually increased
across blocks in Wistar rats (n¼ 12) and Long–Evans rats (n¼ 11; **Po0.01, significant difference between blocks).
(b) Discriminability was consistent across blocks in both rat strains, indicating that the change in response bias was not a function of a
change in the ability to differentiate the two ambiguous tone durations but rather a function of reinforcement history. The increased response
bias was reflected by greater accuracy for the rich stimulus compared with the lean stimulus across blocks in both (c) Wistar and (d) Long–
Evans rats (*Po0.05, **Po0.01 and ***Po0.001, significant difference between rich and lean stimuli). Consistent with the differential
reinforcement schedule, across rat strains, rich accuracy increased from block 1 to block 2 (t22¼ 2.39, Po0.05) and block 3 (t22¼ 2.00,
P¼ 0.058), whereas lean accuracy decreased from block 1 to block 2 (t22¼  2.06, P¼ 0.051) and block 3 (t22¼  2.29, Po0.05). Reaction times
decreased for the rich stimulus compared with the lean stimulus in (e) Wistar, but not (f ) Long–Evans, rats (**Po0.01, significant difference
between rich and lean stimuli).
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declined over the course of the test session in both Wistar and
Long–Evans rats, a pattern that is observed in healthy human
subjects as well.5 In contrast to Long–Evans rats, reaction times in
Wistar rats decreased and increased when responding to the rich
and lean stimuli, respectively, also similar to the pattern of
responding in healthy human subjects.5 Thus, the four measures
(response bias, discriminability, accuracy and reaction time)
collected from Wistar rats are virtually identical to those of
human subjects,5 suggesting that the two tests are analogous, and
Wistar rats use similar strategies and patterns of responding as
healthy human subjects. After having established these important
psychometric properties, the overarching goal of the next two
experiments was to determine whether reward responsiveness
could be modulated by pharmacological challenges hypothesized
to affect dopaminergic/monoaminergic neurotransmission.
Several lines of evidence suggest that reward responsiveness
is partially regulated by mesocorticolimbic dopaminergic
circuits.28,29 First, healthy subjects who developed a response
bias in the PRT showed increased striatal activation after reward
feedback in a different task.30 Second, subjects with MDD were
Figure 2. Effects of pramipexole on reward responsiveness. Relative to saline, pramipexole administration reduced (a) response bias and
(b) discriminability (n¼ 16; *Po0.05, significantly different from saline). (c, d) The pramipexole-induced attenuation of response bias was
reflected by greater accuracy for the rich stimulus in saline-treated rats compared with pramipexole-treated rats (***Po0.001, significantly
greater than saline/lean; #Po0.05, significantly greater than pramipexole/rich).
Figure 3. Effects of amphetamine on reward responsiveness. Relative to saline, amphetamine administration (a) potentiated response bias
(n¼ 22; *Po0.05, significantly greater than saline) (b) without affecting discriminability (*Po0.05, significant difference between blocks).
(c, d) The amphetamine-induced potentiation of response bias was reflected by greater accuracy for the rich stimulus in amphetamine-treated
rats compared with saline-treated rats (*Po0.05, significantly greater than saline/lean; ***Po0.001, significantly greater than amphetamine/
lean; #Po0.05, significantly greater than saline/rich).
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characterized by both blunted response bias6 and reduced striatal
responses to monetary rewards in a different task.31 Third, in
humans, we are able to model blunted reward responsiveness in a
computational model of frontostriatal circuitry by postulating
reduced phasic dopaminergic bursts in response to rewards.28
Fourth, and directly relevant to the present ﬁndings, putatively
reduced dopamine transmission (achieved by means of low
pramipexole doses hypothesized to reduce dopaminergic trans-
mission through autoreceptor activation) was found to reduce
response bias in the PRT in healthy subjects compared with
placebo-treated controls.15
Consistent with the above results, pramipexole attenuated
response bias in rats. In light of prior evidence that similar
pramipexole doses suppressed ﬁring of ventral tegmental area
dopaminergic neurons20,21 and striatal dopamine levels22,23
in rats, we speculate that the reduced reward responsiveness
that emerged from the current study resulted from decreased
striatal dopamine function. Although the clinical evidence of a
dopaminergic mechanism underlying reward responsiveness
described above is largely correlational, development of the PRT
in rats will allow for a direct test of this hypothesis.
Pramipexole also impaired discriminability compared with
saline treatment. The analyses of accuracy data clariﬁed, however,
that this ﬁnding was driven by the fact that pramipexole-treated
rats were less accurate than saline-treated rats in identifying the
rich stimulus. In addition, unlike saline-treated rats, pramipexole-
treated rats failed to show the expected higher accuracy for the
more frequently reinforced rich stimulus relative to the lean
stimulus. Together, these selective deﬁcits in responding for the
rich stimulus indicate that blunted response bias in the
pramipexole-treated group was not due to general difﬁculties
with the task. Finally, consistent with prior reports that low doses
of pramipexole suppressed locomotor activity in rats,32
pramipexole-treated rats had slower reaction times than saline-
treated rats. These results mirror data showing that healthy
humans who received low doses of pramipexole15 and subjects
with MDD6 had slower reaction times during the PRT compared
with placebo-treated and healthy controls, respectively. Collec-
tively, these ﬁndings suggest that a low dose of pramipexole
blunted the animals’ ability to modulate behavior as a function of
the differential reinforcement schedule.
We further hypothesized that a pharmacological manipulation
known to increase striatal dopamine levels would enhance reward
responsiveness. In support of this hypothesis, acute amphetamine
administration, which elevates striatal dopamine levels27 and
enhances the sensitivity of brain reward activity in the intracranial
self-stimulation procedure in rats,26 potentiated response bias
compared with saline administration. Consistent with these
results, acute administration via transdermal patches of another
psychomotor stimulant, nicotine, similarly increased response
bias in humans.33 Nicotine administration also elevates striatal
dopamine levels34 and enhances brain reward function in rats.35
Nonetheless, as amphetamine and nicotine have multiple
functions beyond increasing synaptic dopamine levels, further
studies are warranted to elucidate the role of dopamine
speciﬁcally in psychostimulant-induced potentiation of reward
responsiveness.
Notably, although discriminability increased across blocks,
it did so equally in both saline- and amphetamine-treated
rats, indicating that amphetamine-induced potentiation of
response bias was not a function of improved discriminability. In
addition, in contrast to pramipexole-treated rats, amphetamine-
treated rats were signiﬁcantly more accurate for the rich, but not
the lean, stimulus than saline-treated rats, highlighting a
preference for the stimulus paired with more frequent reward.
Thus, converging evidence from computational modeling,28
human imaging studies,30,31 human pharmacological studies15
and the present rodent experiments strongly suggests that
reward responsiveness is at least partially mediated by striatal
dopaminergic mechanisms.
Although it is expected that the differential reinforcement
schedule alone should bias responding for the more frequently
reinforced stimulus in control subjects,36 the signal detection
aspect of the task combined with a moderate degree of ambiguity
between the target stimuli likely plays an important role in
determining the strength of the bias. Little to no ambiguity
between target stimuli is expected to reduce response bias
irrespective of reward responsiveness, because subjects would be
able to accurately identify each stimulus as they are instructed
(humans) or trained (rats) to do. However, when presented with
two moderately ambiguous stimuli associated with differential
and partial reinforcement, healthy controls quickly develop a
robust response bias (that is, preference) for the stimulus paired
with more frequent rewards in the past. Faced with the same
contingencies, subjects with deﬁcits in reward responsiveness
respond with similar accuracy to both stimuli, indicating that their
behavior is not modulated by reinforcement history. Critically,
such differences emerge even if experimental and control groups
(for example, MDD vs healthy control subjects) are exposed to
identical numbers of reward feedback and rich/lean reward ratio.
Furthermore, it is possible that the differential omission of rewards
after correct rich and lean trials would lead to a differential
extinction of responding. However, it is unlikely that differential
extinction would inﬂuence responding because partial or
intermittent reinforcement schedules, like the one used in the
PRT, are generally resistant to extinction, an effect known as the
partial reinforcement extinction effect.37,38 Thus, the task
parameters used in the present study were sufﬁcient to allow
for the development of a response bias that was mediated by the
differential and partial reinforcement schedules.
As the differential reinforcement schedule is introduced only
during the test session, it is expected that intrasession learning of
the reinforcement schedule occurs if rats develop a response bias.
However, the rate of learning may vary between rats and
experiments. For example, in the task development and amphet-
amine experiments, Wistar, Long–Evans and saline-treated rats
displayed a gradual increase in response bias from blocks 1 to 3,
whereas saline-treated Wistar rats in the pramipexole experiment
displayed a consistently elevated response bias across all three
blocks. Thus, during the task development and amphetamine
experiments, rats likely learned the reinforcement schedule
gradually throughout the three blocks, whereas saline-treated
rats in the pramipexole experiment learned the reinforcement
schedule more rapidly during the ﬁrst block. Indeed, in the
pramipexole experiment, accuracy for the rich stimulus peaked
and was greater than accuracy for the lean stimulus during block 1
in saline-treated rats, reﬂecting learning of the differential
reinforcement schedule during the initial block of testing. It is
noteworthy that the rate of learning varies among human subjects
and experiments in the human PRT as well. Although some
healthy control subjects develop a response bias gradually
throughout the test session,5,8,15,39 others appear to learn the
reinforcement contingencies within the ﬁrst block of trials and
display a consistently elevated response bias throughout the test
session.6,7,9,33
One limitation of the current studies is the use of food
restriction, which is often required in rodents to ensure task
performance. Potentiated responding for a more frequently
reinforced stimulus may thus reﬂect increased motivation to
obtain the food reward. However, participants in the human PRT
are likely similarly motivated by the opportunity to earn money.
Still, differences in values attributed to the rewards may also
inﬂuence response patterns during testing. Furthermore, motiva-
tion and reward responsiveness are both dependent, at least
partially, on dopaminergic neurotransmission.2,11,12,29 Thus, the
impact of motivation and potentially reward valuation on the
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development of response bias cannot be excluded based on the
present studies. Conversely, the fact that response bias in humans
correlates with subjective anhedonia measures does not
necessarily imply that reward responsiveness is mediated by
hedonic capacity or pleasure. Rather, most self-report measures of
human anhedonia do not discriminate among impairments in
discrete reward processes, such as reward responsiveness,
motivation and valuation, yet deﬁcits in these processes may be
expressed during subjective assessments and imprecisely labeled
as anhedonia. Indeed, it is argued that hedonic capacity may be
preserved in MDD and that our understanding and assessment of
reward-related processes in psychiatric disorders should be
expanded beyond hedonic capacity.2,4 It should be noted,
however, that anhedonia is deﬁned as a ‘lack of reactivity to
usually pleasurable stimuli’,1 a deﬁnition that may be interpreted
as decreased responsiveness to a monetary or food reward
as in the human and rat PRT, respectively. Nevertheless, the
impact of anhedonia, amotivation and other deﬁcits in reward
processing on reward responsiveness cannot be excluded
and should be separately identiﬁed. It is in this spirit that the
PRT task was developed, with the goal of objectively and reliably
assessing a key component of anhedonic/amotivated behavior,
namely, a reduced ability to modulate behavior as a function
of rewards.
Recently, promising translational behavioral assessments aimed
at characterizing such discrete reward-related processes have
been developed. For example, Treadway et al.40 have developed a
human version of an effort-based decision-making task that is
based on a procedure previously developed by Salamone et al.41
to assess motivational processes in rats. Along similar lines,
Anderson et al.42 have recently developed corresponding human
and rat43 versions of a tone discrimination task to assess
emotional biases based on a similar procedure previously
developed in rats by Enkel et al.44 This latter task also utilizes a
signal-detection approach, but unlike the Response Bias PRT, it
assesses responding for both rewards and the avoidance of
punishment. Furthermore, the Response Bias PRT assesses implicit
learning of reward contingencies during testing, whereas the
emotional bias task assesses emotional responding in subjects
already trained to differentiate reinforcement contingencies. Thus,
each of these tasks assesses different reward-related processes
that are likely mediated by different neurobiological mechanisms.
Together, these tasks provide a new armamentarium to dissect
deﬁcits in reward and motivational processes seen in several
neuropsychiatric disorders into homologous psychological and
neurobiological components and provide a powerful platform for
translational studies across species.
In conclusion, our results highlight the development of a new
behavioral assessment of reward responsiveness in rats that is
conceptually and procedurally analogous to the Response Bias
PRT used in humans and will allow for more direct and
unconfounded investigation of neurobiological mechanisms
underlying reward responsiveness. Along with similar efforts
described above, this approach is expected to bridge the
translational gap that currently exists in psychiatric research45
and promote a better understanding of discrete reward-related
deﬁcits in neuropsychiatric disorders beyond the traditional
deﬁnition of anhedonia.
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